Wagner Lora, Mohrbach Desiree, Ebinger Martin, Endres Matthias, Nolte Christian H, Harmel Peter, Audebert Heinrich J, Rohmann Jessica L, Siegerink Bob
Center for Stroke Research Berlin, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Klinik für Neurologie mit Experimenteller Neurologie, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Front Neurol. 2022 Nov 2;13:1018630. doi: 10.3389/fneur.2022.1018630. eCollection 2022.
Benefits of endovascular thrombectomy (ET) after intravenous thrombolysis (IVT) for patients with acute ischaemic stroke (AIS) have been demonstrated, but analyses of the relationship between IVT-ET time delay and functional outcomes among patients receiving both treatments are lacking.
We used data from the "Berlin-Specific Acute Treatment in Ischaemic and haemorrhAgic stroke with Long-term outcome" (B-SPATIAL) registry. Between January 1st, 2016 and December 31st, 2019, we included patients who received both IVT and ET. The primary outcome was the 3-month ordinal modified Rankin scale (mRS) score. The IVT-ET time delay was analyzed in categories and continuously. We used adjusted ordinal logistic regression to estimate common odds ratios (cOR) and 95% confidence intervals (CI). Secondary analyses involved flexible modeling of IVT-ET delay and dichotomous outcomes.
Of 11,049 patients, 714 who received IVT followed by ET were included. Compared with having an IVT-ET window >120 min (reference), for an IVT-ET window < 30 min, we obtained adjusted cORs for mRS of 0.41 (95% CI: 0.22 to 0.78); and 0.52 (95% CI: 0.33 to 0.82) for 30 to 120 min. Secondary analyses also found protective effects of shorter time delays against "poor" functional outcomes at 3 months.
In patients with AIS, shorter IVT-ET intervals were associated with better 3-month functional outcomes. While the time-to-IVT and time-to-ET include the time until medical attention is received, the IVT-ET time delays fall entirely within the domain of medical management and thus might be easier to optimize.
静脉溶栓(IVT)后行血管内血栓切除术(ET)对急性缺血性卒中(AIS)患者的益处已得到证实,但缺乏对接受两种治疗的患者中IVT-ET时间延迟与功能结局之间关系的分析。
我们使用了“缺血性和出血性卒中的柏林特异性急性治疗及长期结局”(B-SPATIAL)登记处的数据。在2016年1月1日至2019年12月31日期间,我们纳入了接受IVT和ET的患者。主要结局是3个月序贯改良Rankin量表(mRS)评分。对IVT-ET时间延迟进行分类和连续分析。我们使用调整后的序贯逻辑回归来估计共同比值比(cOR)和95%置信区间(CI)。二次分析包括对IVT-ET延迟和二分结局进行灵活建模。
在11049例患者中,纳入了714例先接受IVT后接受ET的患者。与IVT-ET时间窗>120分钟(参考值)相比,对于IVT-ET时间窗<30分钟,我们获得的mRS调整后的共同比值比为0.41(95%CI:0.22至0.78);对于30至120分钟,为0.52(95%CI:0.33至0.82)。二次分析还发现较短的时间延迟对3个月时“不良”功能结局有保护作用。
在AIS患者中,较短的IVT-ET间隔与更好的3个月功能结局相关。虽然到IVT的时间和到ET的时间包括直到获得医疗救治的时间,但IVT-ET时间延迟完全在医疗管理范围内,因此可能更容易优化。